The Proficient Lab is pleased to announce that Sara Beckloff has joined the team as a new advisor to drive growth and innovation.
Posts by:
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition affecting millions of people in the United States. Approximately 7 million (11.4%) U.S. children aged 3–17 years have ever been diagnosed with ADHD, according to a national survey of parents using data from 2022.
HITLAB is proud to announce the final winners of the 2024 Women’s Health Tech Challenge, a prestigious competition designed to recognize and reward innovators developing cutting-edge solutions that address critical unmet needs in women's health.
HITLAB is excited to announce the six finalists for the 2024 Women's Health Tech Challenge (WHTC), selected from a highly competitive pool of innovative digital health solutions aimed at addressing key issues in women's health.
HITLAB is pleased to announce the addition of several leaders to its Breakthrough Alliance (BTA) Board.
HITLAB, a leading healthcare innovation lab, is thrilled to announce a collaboration with the Versalie™ brand to introduce a pioneering competition focused on women’s health, specifically targeting menopause. Building upon the launch of Versalie™1, a new digital-health brand focused on menopause, this Virtual Innovation Challenge aims to source cutting-edge solutions from small startups and entrepreneurs with Minimum Viable Products (MVPs).